ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 726195 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 726195; 2) Community: the network communities that were significantly associated with the response to NSC 726195; 3) Molecule: the relationships between components within communities and NSC 726195; 4) MDR: the compounds that were significantly associated with the NSC 726195.

NSC Compound Enrichment Correlation
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0395466756030208 0.24819572
NSC 303861 L-Cysteine analog 0.0395466756030208 0.2619534
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0395466756030208 0.51828071
NSC 321240 Null 0.0395466756030208 0.15024108
NSC 328410 Camptothecin Derivative 0.0395466756030208 0.13507755
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0395466756030208 0.45027954
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0395466756030208 0.530062
NSC 359239 Antibiotic X-14766A 0.0395466756030208 -0.068971672
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0395466756030208 -0.12047473
NSC 39215 Null 0.0395466756030208 -0.048063802
Total:98  Current:79    [First] [Prev] [Next] [Last]